Ann: Quarterly Operations Review, page-4

"...hotel groups in Thailand, USA and Australia." - most other companies would've made this a separate report.
"A recent technology development is under the working title of Hydroplasma, and involves the direct interaction of plasma with water, eliminating the need for a graphite counter electrode." - good stuff!
"Hydroplasma has attracted interest from certain OEM manufacturers and the Company has commenced preliminary evaluations requested by a US-based white goods OEM that relates to recycling of household water." - wonder who this is? Is there a hint in the following sentence? I believe so.
"The joint tests will also evaluate the ability of Hydroplasma to remove microplastics from household grey and waste water." - - this makes it pretty damn obvious to me. And if my hunch is correct, it could potentially be HUGE. Anyone else care to take a guess? I suggest members do some reading on microplastics. If Hydroplasma can handle microplastics, it's game, set & match for PO3.
"Consequently, the Company clarified that the technology had not been tested on the surfacebound SARS-CoV-2 surrogates as per TGA prescribed methodology. The Board has now chosen to rectify this issue and is planning to validate the claim at a suitable GLP-accredited laboratory. " - about bloody time!

All in all, a very conservatively written report, displaying plenty of progress on multiple fronts.